RIAS
KRYS icon

Rachor Investment Advisory Services’s Krystal Biotech KRYS Stock Holding History

Rachor Investment Advisory Services’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$2.07K – 313
2026
Q1 		$2.07K Buy
+8
New +$2.13K ﹤0.01% 256

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Rachor Investment Advisory Services's KRYS Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Krystal Biotech (KRYS) in Q2 2026, closing a stake of 8 shares — an estimated $2.07K sold.

Rachor Investment Advisory Services first reported a position in KRYS in Q1 2026 and held it in 1 quarter. The position peaked at $2.07K in Q1 2026. 83 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Krystal Biotech position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 8 Krystal Biotech shares in Q2 2026, an estimated $2.07K.
  • Rachor Investment Advisory Services first reported a position in Krystal Biotech in Q1 2026 and held it in 1 quarter.
  • Rachor Investment Advisory Services's Krystal Biotech position peaked at $2.07K in Q1 2026.
  • 83 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.